AN2 Therapeutics (ANTX) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Buy or Sell AMZN stocks? (AMZN) forecasting

Amazon’s Stock Looks Cheap

February 29, 2024
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

AN2 Therapeutics (ANTX) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: March 1, 2024 (11:09)

Sector: Healthcare

The share price of AN2 Therapeutics, Inc. (ANTX) now

Latest session on the 29th of February for
AN2 Therapeutics, Inc. is negative
Trading Volume: 778253
Open: 3 /  High: 3.25 /  Low: 2.98
What analysts predict: $20
52-week High/Low: $22.22 / $3.13

50/200 Day Moving Average: $17.8 / $13.04

This figure corresponds to the Average Price over the previous 50/200 days. For AN2 Therapeutics stocks, the 50-day moving average is the resistance level today.

For AN2 Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in AN2 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the AN2 Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one AN2 Therapeutics share be worth in 2024 - 2028?

When should I take profit in AN2 Therapeutics stock? When should I record a loss on AN2 Therapeutics stock? What are analysts' forecasts for AN2 Therapeutics stock? What is the future of AN2 Therapeutics stock? We forecast AN2 Therapeutics stock performance using neural networks based on historical data on AN2 Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

AN2 Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for AN2 Therapeutics shares. This happens once a day.


Historical and forecast chart of AN2 Therapeutics stock

The chart below shows the historical price of AN2 Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AN2 Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

AN2 is developing treatments for rare, chronic, and serious infectious diseases. Its initial product candidate is epetraborole, a once-daily oral drug that aims to treat chronic nontuberculous mycobacterial lung disease.
The biotech is the second company to open for trading in March. The first was Akanda (ticker: AKAN), a medical-cannabis company, which listed its shares on March 15, soaring 163% in its debut. Akanda stock is down about 18% from the $10.50 first-day closing price but still up 116% from the $4 IPO price.

AN2 Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 03 3.08 3.06 3.10 1.47
Mar 04 3.08 3.06 3.12 2.12
Mar 05 3.11 3.04 3.14 3.03
Mar 06 3.08 3.04 3.14 3.25
Mar 07 3.10 3.04 3.14 3.11
Mar 08 3.18 3.14 3.24 3.09
Mar 09 3.16 3.13 3.19 2.18
Mar 10 3.19 3.17 3.22 1.77
Mar 11 3.18 3.12 3.21 2.73
Mar 12 3.12 3.08 3.17 2.81
Mar 13 3.08 3.01 3.10 2.87
Mar 14 3.11 3.07 3.13 1.89
Mar 15 3.19 3.13 3.21 2.70
Mar 16 3.27 3.21 3.34 4.16
Mar 17 3.27 3.24 3.31 2.32
Mar 18 3.27 3.23 3.30 2.02
Mar 19 3.24 3.21 3.30 2.67
Mar 20 3.20 3.18 3.22 1.39
Mar 21 3.13 3.09 3.15 2.00
Mar 22 3.14 3.07 3.16 2.79
Mar 23 3.14 3.11 3.17 1.88
Mar 24 3.12 3.08 3.16 2.63
Mar 25 3.14 3.08 3.16 2.53
Mar 26 3.12 3.09 3.18 3.00
Mar 27 3.18 3.16 3.20 1.39
Mar 28 3.25 3.20 3.28 2.41
Mar 29 3.22 3.19 3.28 2.75
Mar 30 3.22 3.17 3.27 2.96
Mar 31 3.15 3.09 3.20 3.32
Apr 01 3.19 3.13 3.22 2.94

AN2 Therapeutics Daily Price Targets


AN2 Therapeutics Stock Forecast 03-03-2024.

Forecast target price for 03-03-2024: $3.08.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 1.449%.
Pessimistic target level: 3.06
Optimistic target level: 3.10

AN2 Therapeutics Stock Forecast 03-04-2024.

Forecast target price for 03-04-2024: $3.08.
Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.076%.
Pessimistic target level: 3.06
Optimistic target level: 3.12

AN2 Therapeutics Stock Forecast 03-05-2024.

Forecast target price for 03-05-2024: $3.11.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.941%.
Pessimistic target level: 3.04
Optimistic target level: 3.14

AN2 Therapeutics Stock Forecast 03-06-2024.

Forecast target price for 03-06-2024: $3.08.
Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.151%.
Pessimistic target level: 3.04
Optimistic target level: 3.14

AN2 Therapeutics Stock Forecast 03-07-2024.

Forecast target price for 03-07-2024: $3.10.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.019%.
Pessimistic target level: 3.04
Optimistic target level: 3.14

AN2 Therapeutics Stock Forecast 03-08-2024.

Forecast target price for 03-08-2024: $3.18.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.996%.
Pessimistic target level: 3.14
Optimistic target level: 3.24

ANTX (ANTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 2.87 2.71 3.04 11.09
May. 3.00 2.87 3.09 6.85
Jun. 2.92 2.81 3.10 9.07
Jul. 2.74 2.67 2.88 7.24
Aug. 2.65 2.50 2.82 11.28
Sep. 2.83 2.70 2.97 9.15
Oct. 2.75 2.61 2.83 7.54
Nov. 2.74 2.59 2.90 10.78
Dec. 2.79 2.64 2.87 8.24

AN2 Therapeutics forecast for this year


AN2 Therapeutics Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $2.87034. Pessimistic: $2.71. Optimistic: $3.04


AN2 Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $3.00122. Pessimistic: $2.87. Optimistic: $3.09


AN2 Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $2.92439. Pessimistic: $2.81. Optimistic: $3.10


AN2 Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $2.74191. Pessimistic: $2.67. Optimistic: $2.88


AN2 Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $2.64759. Pessimistic: $2.50. Optimistic: $2.82


AN2 Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $2.82762. Pessimistic: $2.70. Optimistic: $2.97


AN2 Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $2.74619. Pessimistic: $2.61. Optimistic: $2.83


AN2 Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $2.7374. Pessimistic: $2.59. Optimistic: $2.90


AN2 Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $2.79434. Pessimistic: $2.64. Optimistic: $2.87



AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.58 2.46 2.62 6.14
Feb 2.61 2.54 2.70 5.88
Mar 2.63 2.53 2.76 8.61
Apr 2.56 2.40 2.64 9.01
May 2.48 2.42 2.58 6.00
Jun 2.60 2.47 2.70 8.64
Jul 2.77 2.70 2.94 7.92
Aug 2.86 2.68 2.91 7.80
Sep 2.95 2.89 3.10 6.99
Oct 2.87 2.73 3.01 9.02
Nov 2.75 2.70 2.92 7.83
Dec 2.79 2.63 2.86 7.87

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.89 2.71 3.07 11.67
Feb 2.86 2.81 3.00 6.04
Mar 3.07 2.98 3.14 5.16
Apr 3.17 3.05 3.37 9.41
May 3.24 3.04 3.40 10.59
Jun 3.20 3.06 3.30 7.29
Jul 2.97 2.90 3.08 6.00
Aug 3.00 2.81 3.15 10.59
Sep 2.79 2.69 2.89 6.78
Oct 2.56 2.44 2.67 8.74
Nov 2.69 2.58 2.82 8.47
Dec 2.61 2.53 2.66 5.10

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 2.69 2.55 2.81 9.18
Feb 2.79 2.66 2.93 8.92
Mar 2.74 2.64 2.83 6.65
Apr 2.65 2.60 2.71 4.37
May 2.57 2.50 2.73 8.73
Jun 2.65 2.52 2.74 7.90
Jul 2.69 2.52 2.84 11.14
Aug 2.56 2.48 2.66 6.62
Sep 2.65 2.55 2.77 7.89
Oct 2.66 2.53 2.80 9.82
Nov 2.61 2.55 2.69 5.26
Dec 2.73 2.67 2.85 6.20

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 2.83 2.65 2.99 11.30
Feb 3.03 2.97 3.12 4.96
Mar 3.19 3.05 3.26 6.34
Apr 3.18 3.03 3.26 6.95
May 3.27 3.11 3.45 9.80
Jun 3.43 3.24 3.48 6.92
Jul 3.51 3.30 3.65 9.60
Aug 3.56 3.49 3.69 5.49
Sep 3.64 3.48 3.82 8.92
Oct 3.41 3.29 3.46 4.88
Nov 3.42 3.34 3.57 6.45
Dec 3.43 3.31 3.60 7.99

AN2 Therapeutics information and performance

AN2 Therapeutics Address

1800 EL CAMINO REAL, SUITE D, MENLO PARK, CA, US

Market Capitalization: 99 039 000 $

Market capitalization of the AN2 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ANTX shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA of AN2 Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.8

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.0599

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 29741400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.